Research compound

This compound is primarily studied in research/clinical settings & may not be widely available as a regulated over-the-counter supplement. Information is provided for educational purposes only — not as a recommendation to use. See our Safety page.

CJC-1295

CJC-1295 is a growth hormone-releasing hormone (GHRH) analogue that elevates GH and IGF-1 levels, with the DAC form providing sustained effects suitable for anti-aging and body composition goals.

growth-hormonebody-compositionrecoveryanti-aging

Evidence last reviewed: 19 Apr 2026

Buy this ingredient ← Back

Supplement note

Private note on this supplement

Save how you reacted, what dose worked, what to watch for, or anything you want to remember later in your Notes tab.

Biomarkers studied

Outcomes directly measured across the evidence records below

Hormonal

Growth HormoneIGF-1

Evidence

1 record

Sustained GH and IGF-1 elevation

Healthy adults • RCT

PUBMEDModerate

CJC-1295 DAC significantly prolonged GH and IGF-1 secretion compared to baseline.

Dose: 2000 mgDuration: Once or twice weeklyForm: CJC-1295 DAC

Citation: Teichman et al. (2006). Prolonged stimulation of growth hormone (GH) and insulin-like growth factor I secretion by CJC-1295, a long-acting analog of GH-releasing hormone, in healthy adults. Journal of Clinical Endocrinology & Metabolism.

Forms

CJC-1295 no-DAC

Short-acting form with a half-life of approximately 30 minutes.

CJC-1295 DAC

Long-acting form with a half-life of approximately 8 days, allowing for less frequent dosing.

Stacks containing CJC-1295

Public community stacks that include this ingredient.

Explore all stacks →

No public stacks include this ingredient yet.